Wegovy Insurance Coverage
About 40-50% of commercial plans cover Wegovy. Medicare does not cover weight loss drugs. Prior authorization tips, appeal strategies, and alternative paths.
Commercial coverage
~40-50% of plans
Medicare Part D
Not covered
Prior auth required
Nearly always
Appeal success rate
~40-50% external
Savings card
Up to $500/fill off
Current Coverage Landscape
Wegovy insurance coverage has improved significantly since its 2021 launch but remains far from universal. As of 2026, approximately 40-50% of commercially insured Americans have access to Wegovy coverage through their health plans. This represents steady growth as employers and insurers recognize the long-term cost savings of treating obesity.
Coverage criteria typically require BMI >= 30 (or >= 27 with comorbidities), prior authorization, and documentation of previous weight management attempts. Some plans impose additional requirements like behavioral counseling or waiting periods.
Getting Prior Authorization Approved
To maximize approval chances: compile thorough documentation of BMI history, weight-related comorbidities (hypertension, sleep apnea, type 2 diabetes/prediabetes, PCOS, dyslipidemia, GERD, osteoarthritis), previous diet and exercise attempts, and any prior weight loss programs or medications.
Your provider's letter of medical necessity should explain why Wegovy is specifically needed, citing the SELECT cardiovascular outcomes data for patients with cardiovascular risk. Including relevant lab work strengthens the case.
When Denied: Appeal Process
If denied, request the formal denial letter and file an internal appeal addressing the specific reason. Common denial reasons and responses: BMI not meeting criteria (provide historical BMI data showing chronic obesity), insufficient prior attempts (document all diet, exercise, and behavioral efforts), not on formulary (request formulary exception citing medical necessity).
If the internal appeal fails, file an external appeal. External independent reviews overturn approximately 40-50% of prior authorization denials for anti-obesity medications.
Alternative Paths to Semaglutide
If Wegovy is not covered: check if your plan covers Ozempic for diabetes (if you have type 2 diabetes or prediabetes, this may be a covered path to semaglutide). Consider compounded semaglutide from verified telehealth providers ($149-$450/month). Check if your employer offers a separate weight management benefit. Explore the Wegovy Savings Card if you have any commercial coverage.
Frequently Asked Questions
Does my insurance cover Wegovy?
Check directly with your insurer. Approximately 40-50% of commercial plans now cover Wegovy. Coverage depends on your specific plan's formulary, which can change annually.
Can I get Wegovy through Medicare?
Medicare Part D currently does not cover weight loss medications including Wegovy. The TREAT Act, if passed, would change this. Some Medicare Advantage plans may offer supplemental coverage.
What if Wegovy is denied by insurance?
Always appeal. Request the denial letter, address the specific reason, and file an internal appeal with additional documentation. If denied again, file an external appeal -- about 40-50% are overturned.
Find providers who help navigate Wegovy insurance coverage
Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.
Search Providers →Explore all Semaglutide topics
Cost guides, side effect management, dosing information, insurance coverage, and more — all backed by clinical data.